Loading...

We've got a brand new version of Simply Wall St! Try it out

High Tide

CNSX:HITI
Snowflake Description

Slightly overvalued with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
HITI
CNSX
CA$72M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada. The last earnings update was 87 days ago. More info.


Add to Portfolio Compare Print
HITI Share Price and Events
7 Day Returns
-4.1%
CNSX:HITI
-5.9%
CA Pharmaceuticals
1.3%
CA Market
1 Year Returns
-
CNSX:HITI
-46.7%
CA Pharmaceuticals
-0.1%
CA Market
HITI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
High Tide (HITI) -4.1% -2.8% -4.1% - - -
CA Pharmaceuticals -5.9% -3.4% -24.8% -46.7% 217.3% 286.4%
CA Market 1.3% 4.2% 1.6% -0.1% 8.4% 5.7%
1 Year Return vs Industry and Market
  • No trading data on HITI.
  • No trading data on HITI.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is High Tide undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of High Tide to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for High Tide.

CNSX:HITI Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.2%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:HITI
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.7
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.698 (1 + (1- 26.5%) (25.46%))
0.885
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.89
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.885 * 5.96%)
7.22%

Discounted Cash Flow Calculation for CNSX:HITI using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for High Tide is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:HITI DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (CAD, Millions) Source Present Value
Discounted (@ 7.22%)
2020 -3.79 Analyst x1 -3.53
2021 16.73 Analyst x1 14.55
2022 20.86 Analyst x1 16.92
2023 23.94 Est @ 14.75% 18.11
2024 26.55 Est @ 10.91% 18.73
2025 28.73 Est @ 8.22% 18.91
2026 30.56 Est @ 6.34% 18.75
2027 32.09 Est @ 5.02% 18.37
2028 33.40 Est @ 4.1% 17.83
2029 34.56 Est @ 3.45% 17.20
Present value of next 10 years cash flows CA$155.00
CNSX:HITI DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= CA$34.56 × (1 + 1.95%) ÷ (7.22% – 1.95%)
CA$667.63
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= CA$667.63 ÷ (1 + 7.22%)10
CA$332.37
CNSX:HITI Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= CA$155.00 + CA$332.37
CA$487.37
Equity Value per Share
(CAD)
= Total value / Shares Outstanding
= CA$487.37 / 206.47
CA$2.36
CNSX:HITI Discount to Share Price
Calculation Result
Value per share (CAD) From above. CA$2.36
Current discount Discount to share price of CA$0.35
= -1 x (CA$0.35 - CA$2.36) / CA$2.36
85.2%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price High Tide is available for.
Intrinsic value
>50%
Share price is CA$0.35 vs Future cash flow value of CA$2.36
Current Discount Checks
For High Tide to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • High Tide's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • High Tide's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for High Tide's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are High Tide's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:HITI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-04-30) in CAD CA$-0.08
CNSX:HITI Share Price ** CNSX (2019-09-20) in CAD CA$0.35
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 15.3x
Canada Market PE Ratio Median Figure of 539 Publicly-Listed Companies 14.14x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of High Tide.

CNSX:HITI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:HITI Share Price ÷ EPS (both in CAD)

= 0.35 ÷ -0.08

-4.15x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • High Tide is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • High Tide is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does High Tide's expected growth come at a high price?
Raw Data
CNSX:HITI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -4.15x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.56x
Canada Market PEG Ratio Median Figure of 245 Publicly-Listed Companies 1.02x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for High Tide, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on High Tide's assets?
Raw Data
CNSX:HITI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-04-30) in CAD CA$0.12
CNSX:HITI Share Price * CNSX (2019-09-20) in CAD CA$0.35
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.36x
Canada Market PB Ratio Median Figure of 2,457 Publicly-Listed Companies 1.43x
CNSX:HITI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:HITI Share Price ÷ Book Value per Share (both in CAD)

= 0.35 ÷ 0.12

2.88x

* Primary Listing of High Tide.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • High Tide is overvalued based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess High Tide's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. High Tide has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is High Tide expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
32.3%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is High Tide expected to grow at an attractive rate?
  • Unable to compare High Tide's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare High Tide's earnings growth to the Canada market average as no estimate data is available.
  • High Tide's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:HITI Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:HITI Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 32.3%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 97.7%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 56.5%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:HITI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:HITI Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-10-31 134 21 1
2022-10-31 127 20 1
2021-10-31 119 16 1
2020-10-31 80 4 1
2019-10-31 36 -11 1
2019-09-22
CNSX:HITI Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-04-30 15 -5 -12
2019-01-31 11 -13 -9
2018-10-31 9 -9 -5
2018-07-31 9 -2 -1
2017-10-31 10 1 0
2016-10-31 8 0 1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if High Tide is high growth as no earnings estimate data is available.
  • High Tide's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:HITI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from High Tide Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:HITI Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-10-31
2022-10-31
2021-10-31
2020-10-31
2019-10-31
2019-09-22
CNSX:HITI Past Financials Data
Date (Data in CAD Millions) EPS *
2019-04-30 -0.08
2019-01-31 -0.06
2018-10-31 -0.04
2018-07-31 -0.01
2017-10-31 0.03
2016-10-31 3.04

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if High Tide will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess High Tide's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
High Tide has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has High Tide performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare High Tide's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • High Tide does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare High Tide's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare High Tide's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
High Tide's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from High Tide Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:HITI Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-04-30 15.46 -11.53 16.91
2019-01-31 10.82 -8.64 11.95
2018-10-31 8.51 -4.53 6.62
2018-07-31 9.17 -0.67 5.22
2017-10-31 9.83 0.30 3.58
2016-10-31 8.34 1.22 2.60

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if High Tide has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if High Tide has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if High Tide improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess High Tide's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
High Tide has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is High Tide's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up High Tide's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • High Tide is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • High Tide's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of High Tide's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from High Tide Company Filings, last reported 4 months ago.

CNSX:HITI Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-04-30 24.19 18.38 9.30
2019-01-31 25.24 10.36 6.96
2018-10-31 23.32 0.04 8.20
2018-07-31 9.35 0.00 1.69
2017-10-31 -9.66 19.24 1.77
2016-10-31 -9.87 19.14 1.28
  • High Tide's level of debt (76%) compared to net worth is high (greater than 40%).
  • Unable to establish if High Tide's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • High Tide has less than a year of cash runway based on current free cash flow.
  • Unable to confirm if High Tide has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess High Tide's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. High Tide has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is High Tide's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from High Tide dividends.
If you bought CA$2,000 of High Tide shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate High Tide's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate High Tide's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:HITI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.1%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:HITI Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2023-10-31
2022-10-31
2021-10-31
2020-10-31
2019-10-31
2019-09-22

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as High Tide has not reported any payouts.
  • Unable to verify if High Tide's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of High Tide's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as High Tide has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess High Tide's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can High Tide afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. High Tide has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of High Tide's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Raj Grover
COMPENSATION CA$376,536
AGE 37
CEO Bio

Mr. Harkirat Grover also known as Raj, is Founder and serves as Chief Executive Officer, President and Director of High Tide Inc. and served as its Secretary and Treasurer until December 2018.

CEO Compensation
  • Insufficient data for Raj to compare compensation growth.
  • Raj's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the High Tide management team in years:

0.8
Average Tenure
37
Average Age
  • The average tenure for the High Tide management team is less than 2 years, this suggests a new team.
Management Team

Raj Grover

TITLE
Founder
COMPENSATION
CA$377K
AGE
37

Nick Kuzyk

TITLE
Chief Strategy Officer & Senior VP of Capital Markets
COMPENSATION
CA$136K
AGE
39

Rahim Kanji

TITLE
Chief Financial Officer
TENURE
0.3 yrs

Alex Mackay

TITLE
Chief Operating Officer

Andreas Palalas

TITLE
Chief Revenue Officer
AGE
29
TENURE
1.3 yrs

Shimmy Posen

TITLE
Secretary & Treasurer
TENURE
0.8 yrs
Board of Directors Tenure

Average tenure and age of the High Tide board of directors in years:

1
Average Tenure
38
Average Age
  • The average tenure for the High Tide board of directors is less than 3 years, this suggests a new board.
Board of Directors

Raj Grover

TITLE
Founder
COMPENSATION
CA$377K
AGE
37

Nitin Kaushal

TITLE
Director
AGE
53
TENURE
0.9 yrs

Nader Ben Aissa

TITLE
Director
AGE
39
TENURE
1.1 yrs

Arthur Kwan

TITLE
Director
TENURE
1.1 yrs

Shimmy Posen

TITLE
Director
AGE
27
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by High Tide individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
16. Jul 19 Buy BMO Global Asset Management Company 11. Jul 19 12. Jul 19 84,300 CA$0.30 CA$25,262
11. Jul 19 Buy Rahim Kanji Individual 11. Jul 19 11. Jul 19 35,000 CA$0.31 CA$10,850
03. Jul 19 Buy Nader Ben Aissa Individual 26. Jun 19 26. Jun 19 27,777 CA$0.45 CA$12,500
03. Jul 19 Buy Andreas Palalas Individual 26. Jun 19 26. Jun 19 100,000 CA$0.45 CA$45,000
03. Jul 19 Buy Nicholas Kuzyk Individual 26. Jun 19 26. Jun 19 100,000 CA$0.45 CA$45,000
03. Jul 19 Buy Nitin Kaushal Individual 26. Jun 19 26. Jun 19 55,555 CA$0.45 CA$25,000
03. Jul 19 Buy Arthur Kwan Individual 26. Jun 19 26. Jun 19 55,555 CA$0.45 CA$25,000
20. Jun 19 Buy BMO Global Asset Management Company 20. Jun 19 20. Jun 19 8,500 CA$0.35 CA$2,975
18. Jun 19 Buy BMO Global Asset Management Company 17. Jun 19 17. Jun 19 38,000 CA$0.35 CA$13,300
14. Jun 19 Buy BMO Global Asset Management Company 14. Jun 19 14. Jun 19 6,000 CA$0.35 CA$2,100
03. Jun 19 Buy BMO Global Asset Management Company 31. May 19 31. May 19 19,000 CA$0.35 CA$6,650
X
Management checks
We assess High Tide's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. High Tide has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

High Tide Inc. operates as a vertically-integrated company in the cannabis market in Canada. It engages in the design, manufacture, and distribution of cannabis accessories and alternative lifestyle products. The company is also involved in the retailing of cannabis products. As of September 12, 2019, it operated 24 Canna Cabana retail cannabis stores and 13 Smoker's Corner locations. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.

Details
Name: High Tide Inc.
HITI
Exchange: CNSX
Founded: 2009
CA$72,265,685
206,473,386
Website: http://www.hightideinc.com
Address: High Tide Inc.
11127 15 Street NE,
Suite 112,
Calgary,
Alberta, T3K 2M4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX HITI Class A Common Shares Canadian National Stock Exchange CA CAD 17. Dec 2018
OTCPK HITI.F Class A Common Shares Pink Sheets LLC US USD 17. Dec 2018
DB 2LY Class A Common Shares Deutsche Boerse AG DE EUR 17. Dec 2018
Number of employees
Current staff
Staff numbers
0
High Tide employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/22 00:37
End of day share price update: 2019/09/20 00:00
Last estimates confirmation: 2019/09/04
Last earnings filing: 2019/06/27
Last earnings reported: 2019/04/30
Last annual earnings reported: 2018/10/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.